Neurocrine Biosciences (NBIX) Q2 2022 Earnings Call Transcript
With me are Kevin Gorman, our chief executive officer; Matthew Abernethy, our chief financial officer; Eiry Roberts, our chief medical officer; Eric Benevich, our chief commercial officer; and Kyle Gano, our chief business development and strategy officer. During a call, we will be making forward-looking statements.